SuperSonic Imagine announced the launch of the new version of its Aixplorer MACH® 30 ultrasound platform, which introduced 3 new ultrasound markers: Att PLUS, SSp PLUS and Vi PLUS. This new diagnostic approach in ultrasound is made possible due to the new generation of UltraFast™ imaging. SuperSonic Imagine, key innovative player in ultrasound, is now offering a solution to evaluate chronic liver diseases, with three new quantitative markers available on its latest ultrasound platform, Aixplorer MACH 30. Clinicians will now have access to new reliable and reproducible ultrasound markers: Att PLUS and SSp PLUS: these two tools allow for the simultaneous quantification of ultrasound attenuation in the liver and intrahepatic speed of sound, reflecting fat content, an essential indicator for the detection and diagnosis of hepatic steatosis; Vi PLUS: a tool for visualizing and quantifying tissue viscosity. Coupled with real-time elasticity imaging, viscosity assessments provide clinicians with important information for tissue characterization. ShearWave™ PLUS allowing for the real-time visualization and measurement of liver elasticity in Kilopascals for the diagnosis of hepatic fibrosis; the hepato-renal index (B-mode Ratio), serving as an aid in the diagnosis of hepatic steatosis. Angio PL.U.S. Doppler mode,which offers unparalleled resolution in the microvasculature detection and contrast imaging, which provides perfusion information, both furnishing complementary data for the characterization of focal liver lesions. SuperSonic Imagine will introduce its new ultrasound markers for the liver at the 85th edition of the AFEF Scientific Days, booth #13, which will take place in Marseille from 2 to 5 October 2019 and also at the Journées Francophones de Radiologie (JFR), booth #217, level 2, which will be held at the Palais des Congrès in Paris, from 11 to 14 October 2019.